Cantor Fitzgerald Reiterates Overweight on Johnson & Johnson, Maintains $215 Price Target
Johnson & Johnson Analyst Ratings
Johnson & Johnson Analyst Ratings
Cantor Fitzgerald Reiterates Overweight on Johnson & Johnson, Maintains $215 Price Target
Johnson & Johnson Analyst Ratings
Johnson & Johnson Analyst Ratings
RBC Capital Reiterates Outperform on Johnson & Johnson, Maintains $175 Price Target
Halozyme Downgraded at Piper Sandler Despite Guidance Raise
Citigroup Adjusts Price Target on Johnson & Johnson to $180 From $185, Keeps Buy Rating
Johnson & Johnson Analyst Ratings
Royal Bank of Canada: Reiterates the Johnson & Johnson (JNJ.US) rating and adjusted from superior to superior market rating, with a target price of $175.00.
Johnson & Johnson Analyst Ratings
Citi Keeps Their Buy Rating on Johnson & Johnson (JNJ)
Royal Bank of Canada: Reiterates the Johnson & Johnson (JNJ.US) rating and adjusted from superior to superior market rating, with a target price of $175.00.
Johnson & Johnson Analyst Ratings
RBC Capital Reiterates Outperform on Johnson & Johnson, Maintains $175 Price Target
Johnson & Johnson (JNJ) Receives a Buy From RBC Capital
Cantor Fitzgerald: Reiterated the Johnson & Johnson (JNJ.US) rating and adjusted from an increase to an increase in holdings rating, with a target price of $215.00.
Johnson & Johnson Analyst Ratings
Cantor Fitzgerald Reiterates Overweight on Johnson & Johnson, Maintains $215 Price Target